LU84910A1 - Perfectionnements a des compositions d'alcaloides de vinca - Google Patents

Perfectionnements a des compositions d'alcaloides de vinca Download PDF

Info

Publication number
LU84910A1
LU84910A1 LU84910A LU84910A LU84910A1 LU 84910 A1 LU84910 A1 LU 84910A1 LU 84910 A LU84910 A LU 84910A LU 84910 A LU84910 A LU 84910A LU 84910 A1 LU84910 A1 LU 84910A1
Authority
LU
Luxembourg
Prior art keywords
solution
composition according
approximately
sulfate
vincristine
Prior art date
Application number
LU84910A
Other languages
English (en)
French (fr)
Inventor
Robert Lee Robison
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU84910A1 publication Critical patent/LU84910A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU84910A 1982-07-19 1983-07-13 Perfectionnements a des compositions d'alcaloides de vinca LU84910A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39965482A 1982-07-19 1982-07-19
US39965482 1982-07-19
US47607783A 1983-03-17 1983-03-17
US47607783 1983-03-17

Publications (1)

Publication Number Publication Date
LU84910A1 true LU84910A1 (fr) 1985-04-17

Family

ID=27016716

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84910A LU84910A1 (fr) 1982-07-19 1983-07-13 Perfectionnements a des compositions d'alcaloides de vinca

Country Status (16)

Country Link
AU (1) AU553514B2 (nl)
BE (1) BE897280A (nl)
CH (1) CH654744A5 (nl)
DE (1) DE3324964A1 (nl)
FR (1) FR2531860B1 (nl)
GB (1) GB2125292B (nl)
HK (1) HK43087A (nl)
HU (1) HU191538B (nl)
IE (1) IE55388B1 (nl)
IL (1) IL69203A (nl)
IT (1) IT1170152B (nl)
LU (1) LU84910A1 (nl)
NL (1) NL184146C (nl)
NZ (1) NZ204868A (nl)
PH (1) PH19098A (nl)
SE (1) SE463804B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
ES2823281T3 (es) 2015-08-01 2021-05-06 Sun Pharmaceutical Ind Ltd Forma de dosificación del fármaco alcaloide vinca

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3749784A (en) * 1972-05-03 1973-07-31 Lilly Co Eli Psoriasis treatment
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4208414A (en) * 1978-06-05 1980-06-17 Eli Lilly And Company Vinblastine in rheumatoid arthritis
US4259242A (en) * 1978-10-10 1981-03-31 Eli Lilly And Company Method of preparing vindesine sulfate
HU181940B (en) * 1979-11-02 1983-11-28 Richter Gedeon Vegyeszet Process for producing solutions of vincane derivatives for parentheral application
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.

Also Published As

Publication number Publication date
AU553514B2 (en) 1986-07-17
SE8304009D0 (sv) 1983-07-15
NL184146B (nl) 1988-12-01
IE831646L (en) 1984-01-19
BE897280A (fr) 1984-01-13
AU1689183A (en) 1984-01-26
CH654744A5 (de) 1986-03-14
HK43087A (en) 1987-06-05
IL69203A (en) 1986-03-31
GB8319146D0 (en) 1983-08-17
GB2125292B (en) 1986-06-04
PH19098A (en) 1986-01-02
IL69203A0 (en) 1983-11-30
FR2531860A1 (fr) 1984-02-24
FR2531860B1 (fr) 1986-09-26
GB2125292A (en) 1984-03-07
SE8304009L (sv) 1984-01-20
SE463804B (sv) 1991-01-28
HU191538B (en) 1987-03-30
IE55388B1 (en) 1990-08-29
DE3324964A1 (de) 1984-01-19
NL184146C (nl) 1989-05-01
IT8321644A0 (it) 1983-06-15
DE3324964C2 (nl) 1991-03-14
NL8302552A (nl) 1984-02-16
IT1170152B (it) 1987-06-03
NZ204868A (en) 1986-10-08

Similar Documents

Publication Publication Date Title
US9265832B2 (en) Stabilized pemetrexed formulation
US9629844B2 (en) Stabilized pemetrexed formulation
CH695185A5 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame et procede pour leur production.
OA10678A (fr) Nouvelles formulations liquides stables à base de paracétamol et leur mode de préparation
US6686365B2 (en) Pharmaceutical composition
WO2013144814A1 (en) Stable ready-to-use pharmaceutical composition of pemetrexed
JP2020125359A (ja) ペメトレキセドまたはその薬剤学的に許容可能な塩を含有する安定化された薬学組成物
CA2399124A1 (en) Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
LU84910A1 (fr) Perfectionnements a des compositions d'alcaloides de vinca
CA2551493C (fr) Composition pharmaceutique de vinflunine destinee a une administration parenterale, procede de preparation et utilisation
US4619935A (en) Stable oncolytic formulations
EP2114372B1 (en) Pharmaceutical carrier composition and pharmaceutical composition
CN100438863C (zh) 一种盐酸曲马多冻干粉针剂及其制备方法
JPS5929617A (ja) ビンカ・アルカロイド製剤
CN100364524C (zh) 注射用萘普生钠无菌冻干制剂及其制备方法
WO2024100679A1 (en) Parenteral formulations of flucytosine
CN113350271A (zh) 一种质子泵抑制剂的组合物及其制备方法
CN102018664A (zh) 一种化合物/氯化钠制剂
TH71176B (th) กรรมวิธีสำหรับการเตรียมสูตรผสมของเอโพไธโลนแอนาลอกที่มีหมู่แทนที่อยู่ในโครงสร้างในการเตรียมยาสำหรับการรักษามะเร็ง
TH60657A (th) กรรมวิธีสำหรับการเตรียมสูตรผสมของเอโพไธโลนแอนาลอกที่มีหมู่แทนที่อยู่ในโครงสร้างในการเตรียมยาสำหรับการรักษามะเร็ง